Recently published results from the Cardiovascular and Interventional Radiological Society of Europe (“CIRSE”) vascular closure device registry further validated the safety and efficacy of medical ...
June 2, 2010 (Kansas City, Missouri) — A treatment strategy that involves the use of a vascular closure device and bivalirudin (Angiomax, the Medicines Company) reduces the risk of periprocedural ...
BURLINGTON, MA — An active surveillance system now available as an open-source tool found that the relative risk of vascular complications was increased 60% for patients receiving Mynx (Cardinal ...
WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results